Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

Antimicrobial activity of cationic carbosilane dendrimers against clinical strains of extended-spectrum beta-lactamase producing-Escherichia coli and their biofilms

  • Hernando Gozalo, Marcos|||0000-0003-2838-7270
  • Aguilera Correa, John Jairo
  • Ciepluch, Karol
  • Lach, Karolina
  • Rescalvo Casas, Carlos|||0000-0003-3745-6661
  • Seijas Pereda, Laura
  • Cuadros González, Juan|||0000-0003-4098-4377
  • Gómez Ramírez, Rafael|||0000-0001-6448-2414
  • Pérez Tanoira, Ramón|||0000-0002-9816-3208
  • Sánchez-Nieves Fernández, Javier|||0000-0003-0410-2285
12 p., Antimicrobial resistance (AMR) is a significance public health concern with serious health and socioeconomic consequences. Therefore, multidrug-resistant strains such as extended-spectrum beta-lactamase (ESBL) producing-Enterobacterales are becoming increasingly common and there are few antibiotic options to treat them. Consequently, it is urgent to find new therapeutic compounds, and cationic dendrimers, such as carbosilane (CBS) derivatives, with peripheral ammonium groups are possible candidates for this purpose. The aim of this study was to establish the antimicrobial and biological properties of different cationic CBS dendrimers and dendrons against multiresistant clinical strains of ESBL-producing Escherichia coli. All seven compounds tested were found to be effective in vitro against planktonic forms. The most active compounds inhibited the formation of bacterial biofilms but lacked activity against pre-formed biofilms. These dendrimers differed in their mode of action depending on the structure and the cationic groups, which was analysed by studies with interaction of membrane models. In addition, these four dendritic systems mentioned above showed a good therapeutic margin in the haemolysis assays in vitro and they lacked haemagglutinating properties. In conclusion, some of the compounds tested could be candidates as potential topical antimicrobials or disinfectants against ESBL-producing enterobacteria infections., Ministerio de Ciencia e Innovación, Comunidad de Madrid, Universidad de Alcalá, Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Instituto de Salud Carlos III, Unión Europea, Fundación para la Investigación Biomédica del Hospital Universitario Príncipe de Asturias, National Science Centre (Polonia)
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

A new guanidine-core small-molecule compound as a potential antimicrobial agent against resistant bacterial strains

  • Morata Moreno, Noelia
  • Pérez Tanoira, Ramón|||0000-0002-9816-3208
  • Del Campo Balguerías, Almudena
  • Carrillo Hermosilla, Fernando
  • Hernando Gozalo, Marcos|||0000-0003-2838-7270
  • Rescalvo Casas, Carlos|||0000-0003-3745-6661
  • Ocaña García, Verónica
  • Seguí, Pedro
  • Alonso Moreno, Carlos
  • Pérez Martínez, Francisco Carlos
  • Molina Alarcón, Milagros
11 p., The guanidine core has been one of the most studied functional groups in medicinal chemistry, and guanylation reactions are powerful tools for synthesizing this kind of compound. In this study, a series of five guanidine-core small molecules were obtained through guanylation reactions. These compounds were then evaluated against three different strains of Escherichia coli, one collection strain from the American Type Culture Collection (ATCC) of E. coli ATCC 35218, and two clinical extended-spectrum beta-lactamase (ESBL)-producing E. coli isolates (ESBL1 and ESBL2). Moreover, three different strains of Pseudomonas aeruginosa were studied, one collection strain of P. aeruginosa ATCC 27853, and two clinical multidrug-resistant isolates (PA24 and PA35). Among Grampositive strains, three different strains of Staphylococcus aureus, one collection strain of S. aureus ATCC 29213, and two clinical methicillin-resistant S. aureus (MRSA1 and MRSA2) were evaluated. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) experiments were reported, and the drop plate (DP) method was used to determine the number of viable suspended bacteria in a known beaker volume. The results from this assessment suggest that guanidine-core small molecules hold promise as therapeutic alternatives for treating infections caused by clinical Gram-negative and Gram-positive bacteria, highlighting the need for further studies to explore their potential. The results from this assessment suggest that the chemical structure of CAPP4 might serve as the basis for designing more active guanidine-based antimicrobial compounds, highlighting the need for further studies to explore their potential.